Rank 91 • MedTech & Devices
Medical Microinstruments (MMI)
Develops the Symani Surgical System, a robotic platform designed for open micro-surgery and lymphatic micro-reconstruction.
Visit website- Signal Score
- 80.5
- Total raised
- $200M
- Stage
- Series C
- Founded
- 2015
- Headquarters
- Pisa, Italy
- Region
- Europe
Their signal
Following a $110 million Series C, MMI's innovative nano-robotic wrist technology allows surgeons to perform highly delicate micro-suturing, filling a critical gap left by traditional laparoscopy platforms.
Signal Score 80.5editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.